Notes
2017 US dollars
glucagon-like peptide-1
Reference
Bagepally BS, et al. Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-analysis. Value in Health : 18 Nov 2019. Available from: URL: https://doi.org/10.1016/j.jval.2019.09.2750
Rights and permissions
About this article
Cite this article
SGLT2 inhibitors cost effective versus sulfonylureas in T2DM. PharmacoEcon Outcomes News 842, 29 (2019). https://doi.org/10.1007/s40274-019-6421-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6421-5